Innovative Migraine Therapies: Navigating Health Canada and FDA Regulatory Pathways.

This paper explores a dual action system combining electrical neuromodulation with transdermal drug delivery through dissolvable microneedles, alongside other groundbreaking technologies like vagus nerve stimulators, magnetic pulse devices, and advanced pharmacological agents. Together, these advancements promise to improve efficacy, reduce side effects, and encourage consistent use, potentially reshaping migraine care on a global scale.